keyword
MENU ▼
Read by QxMD icon Read
search

Inflammatory markers, polycystic ovary syndrome

keyword
https://www.readbyqxmd.com/read/28437620/american-association-of-clinical-endocrinologists-and-american-college-of-endocrinology-guidelines-for-management-of-dyslipidemia-and-prevention-of-cardiovascular-disease
#1
Paul S Jellinger, Yehuda Handelsman, Paul D Rosenblit, Zachary T Bloomgarden, Vivian A Fonseca, Alan J Garber, George Grunberger, Chris K Guerin, David S H Bell, Jeffrey I Mechanick, Rachel Pessah-Pollack, Kathleen Wyne, Donald Smith, Eliot A Brinton, Sergio Fazio, Michael Davidson
OBJECTIVE: The development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the standardized production of clinical practice guidelines (CPGs). METHODS: Recommendations are based on diligent reviews of the clinical evidence with transparent incorporation of subjective factors, according to established AACE/ACE guidelines for guidelines protocols...
April 2017: Endocrine Practice
https://www.readbyqxmd.com/read/28338181/gene-expression-of-inflammatory-markers-in-adipose-tissue-between-obese-women-with-polycystic-ovary-and-normal-obese-women
#2
G Alshammari, R Khan, J Brameld, S Amer, M A Lomax
OBJECTIVE: The pathogenesis of polycystic ovary syndrome (PCOS), a common endocrine disease and metabolic disturbance, is still unknown. The aim of the study was to investigate whether patients with PCOS display increased expression of inflammatory markers in adipose tissue. PATIENTS AND METHODS: Two groups of women were investigated, those diagnosed with PCOS (n = 8) and age and BMI-matched normal women (n = 12). Their age was between 20-45 years and all subjects were apparently healthy and did not take any medications...
March 2017: European Review for Medical and Pharmacological Sciences
https://www.readbyqxmd.com/read/28294594/the-anti-inflammatory-protein-kallistatin-is-associated-with-carotid-intima-media-thickness-in-women-with-polycystic-ovary-syndrome
#3
Mehmet Calan, Aslı Guler, Gokcen Unal Kocabas, Pınar Alarslan, Merve Bicer, Cetin Imamoglu, Arif Yuksel, Giray Bozkaya, Oktay Bilgir
BACKGROUND: Kallistatin is a secreted protein that acts as a tissue kallikrein inhibitor. It has antiinflammatory, antioxidant and vasoprotective properties. Polycystic ovary syndrome (PCOS) is a reproductive and metabolic disease associated with low-grade chronic inflammation and multiple risk factors for cardiovascular diseases. The aims of this study were to ascertain whether circulating kallistatin levels are altered in women with PCOS, and whether there is an association between kallistatin and carotid intima media thickness (cIMT) as well as inflammatory markers high-sensitivity C-reactive protein (hs-CRP) and tumor necrosis factor-α (TNF-α)...
March 14, 2017: Minerva Endocrinologica
https://www.readbyqxmd.com/read/28222828/metabolic-consequences-of-obesity-and-insulin-resistance-in-polycystic-ovary-syndrome-diagnostic-and-methodological-challenges
#4
Yvonne M Jeanes, Sue Reeves
Women with polycystic ovary syndrome (PCOS) have a considerable risk of metabolic dysfunction. This review aims to present contemporary knowledge on obesity, insulin resistance and PCOS with emphasis on the diagnostic and methodological challenges encountered in research and clinical practice. Variable diagnostic criteria for PCOS and associated phenotypes are frequently published. Targeted searches were conducted to identify all available data concerning the association of obesity and insulin resistance with PCOS up to September 2016...
February 22, 2017: Nutrition Research Reviews
https://www.readbyqxmd.com/read/28045919/alterations-in-gut-microbiome-composition-and-barrier-function-are-associated-with-reproductive-and-metabolic-defects-in-women-with-polycystic-ovary-syndrome-pcos-a-pilot-study
#5
Lisa Lindheim, Mina Bashir, Julia Münzker, Christian Trummer, Verena Zachhuber, Bettina Leber, Angela Horvath, Thomas R Pieber, Gregor Gorkiewicz, Vanessa Stadlbauer, Barbara Obermayer-Pietsch
BACKGROUND: Polycystic ovary syndrome (PCOS) is a common female endocrinopathy of unclear origin characterized by hyperandrogenism, oligo-/anovulation, and ovarian cysts. Women with PCOS frequently display overweight, insulin resistance, and systemic low-grade inflammation. We hypothesized that endotoxemia resulting from a leaky gut is associated with inflammation, insulin resistance, fat accumulation, and hyperandrogenemia in PCOS. In this pilot study, we compared the stool microbiome, gut permeability, and inflammatory status of women with PCOS and healthy controls...
2017: PloS One
https://www.readbyqxmd.com/read/28030919/cardiovascular-system-diseases-in-patients-with-polycystic-ovary-syndrome-the-role-of-inflammation-process-in-this-pathology-and-possibility-of-early-diagnosis-and-prevention
#6
REVIEW
Aleksandra Marciniak, Jolanta Nawrocka Rutkowska, Agnieszka Brodowska, Berenika Wiśniewska, Andrzej Starczewski
Polycystic ovary syndrome is a disorder which affects 5-10% of women in reproductive age. PCOS is a cause of hyperandrogenism, menstrual disorders and infertility. The most common clinical symptoms are hirsutism, acne and obesity. Patients often suffer from metabolic disorders: insulin resistance, hyperinsulinemia, dislipidemia, leading to atherosclerosis and others irregularities of the metabolic syndrome. Patients are in the high risk group for cardiovascular diseases (CVD) development because of the metabolic abnormalities...
December 23, 2016: Annals of Agricultural and Environmental Medicine: AAEM
https://www.readbyqxmd.com/read/27651218/endocannabinoid-receptor-blockade-increases-vascular-endothelial-growth-factor-and-inflammatory-markers-in-obese-women-with-polycystic-ovary-syndrome
#7
Thozhukat Sathyapalan, Zeeshan Javed, Eric S Kilpatrick, Anne-Marie Coady, Stephen L Atkin
CONTEXT: Animal studies suggest that cannabinoid receptor-1 (CB-1) blockade reduces inflammation and neovascularization by decreasing vascular endothelial growth factor (VEGF) levels associated with a reduction in inflammatory markers, thereby potentially reducing cardiovascular risk. OBJECTIVE: To determine the impact of CB1 antagonism by rimonabant on VEGF and inflammatory markers in obese PCOS women. DESIGN: Randomized, open-labelled parallel study...
March 2017: Clinical Endocrinology
https://www.readbyqxmd.com/read/27610099/the-salivary-microbiome-in-polycystic-ovary-syndrome-pcos-and-its-association-with-disease-related-parameters-a-pilot-study
#8
Lisa Lindheim, Mina Bashir, Julia Münzker, Christian Trummer, Verena Zachhuber, Thomas R Pieber, Gregor Gorkiewicz, Barbara Obermayer-Pietsch
BACKGROUND: Polycystic ovary syndrome (PCOS) is a common female endocrine condition of unclear etiology characterized by hyperandrogenism, oligo/amenorrhoea, and polycystic ovarian morphology. PCOS is often complicated by infertility, overweight/obesity, insulin resistance, and low-grade inflammation. The gut microbiome is known to contribute to several of these conditions. Recently, an association between stool and saliva microbiome community profiles was shown, making saliva a possible convenient, non-invasive sample type for detecting gut microbiome changes in systemic disease...
2016: Frontiers in Microbiology
https://www.readbyqxmd.com/read/27514712/altered-steroid-metabolism-and-insulin-signaling-in-pcos-endometria-impact-in-tissue-function
#9
Lorena Oróstica, Carlos Rosas, Francisca Plaza-Parrochia, Isis Astorga, Fernando Gabler, Víctor García, Carmen Romero, Margarita Vega
BACKGROUND: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine/ metabolic disorder characterized by hyperandrogenemia and in most cases, by hyperinsulinemia in addition to obesity. Besides ovarian dysfunction, endometrial physiology is also disrupted since this tissue is highly dependent on the action of steroids; in case of conception cycles, high percentage of abortion is observed. Because of the endocrine/metabolic alterations, PCOS-women present high probability to develop hyperplasia and endometrial cancer, where an imbalance of cell proliferation/apoptosis processes is detected...
2016: Current Pharmaceutical Design
https://www.readbyqxmd.com/read/27490918/the-effects-of-soy-isoflavones-on-metabolic-status-of-patients-with-polycystic-ovary-syndrome
#10
Mehri Jamilian, Zatollah Asemi
CONTEXT: Limited data are available evaluating the effects of soy isoflavones on metabolic status of patients with polycystic ovary syndrome (PCOS). OBJECTIVE: The current study was performed to determine the effects of soy isoflavones on metabolic status of patients with PCOS. METHODS: This randomized, double-blind, placebo-controlled trial was performed on 70 women diagnosed with PCOS according to the Rotterdam criteria who were 18-40 years old...
September 2016: Journal of Clinical Endocrinology and Metabolism
https://www.readbyqxmd.com/read/27464726/polycystic-ovary-syndrome-as-a-proinflammatory-state-the-role-of-adipokines
#11
Georgios K Dimitriadis, Ioannis Kyrou, Harpal S Randeva
BACKGROUND: Polycystic Ovary Syndrome (PCOS) is a complex heterogeneous disorder and the most common endocrinopathy amongst women of reproductive age. It is characterized by androgen excess, chronic anovulation and an altered cardiometabolic profile. PCOS is linked to impaired adipose tissue (AT) physiology and women with this disorder present with greater risk for insulin resistance (IR), hyperinsulinemia, central adiposity, nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) than matched for age and body mass index (BMI) women without PCOS...
2016: Current Pharmaceutical Design
https://www.readbyqxmd.com/read/27295433/is-xanthine-oxidase-activity-in-polycystic-ovary-syndrome-associated-with-inflammatory-and-cardiovascular-risk-factors
#12
Hatice Isık, Oner Aynıoglu, Hakan Tımur, Ahmet Sahbaz, Muge Harma, Murat Can, Berrak Guven, Husnu Alptekin, Furuzan Kokturk
The aim of this study is to examine women with polycystic ovary syndrome (PCOS) to determine the relationship between xanthine oxidase (XO) and oxidative stress, inflammatory status, and various clinical and biochemical parameters. In this cross-sectional study a total of 83 women including 45 PCOS patients and 38 healthy women were enrolled. We collected blood samples for XO and superoxide dismutase (SOD) activity, hormone levels, cholesterol values, and inflammatory markers. Body mass index (BMI) , waist-to-hip ratio (WHR), and blood pressure were assessed...
August 2016: Journal of Reproductive Immunology
https://www.readbyqxmd.com/read/27233601/central-leptin-resistance-and-hypothalamic-inflammation-are-involved-in-letrozole-induced-polycystic-ovary-syndrome-rats
#13
Yuling Lian, Fangui Zhao, Wenjun Wang
Accumulating evidence indicates that leptin acts as an important mediator in energy homeostasis and reproduction. Since dysfunction of reproduction and metabolism are major characteristics of polycystic ovarian syndrome (PCOS), the role of leptin in pathogenesis of PCOS needs further research. Many studies have shown that central leptin resistance existed in obesity rats through leptin intracerebroventricular (icv) injection; however, central leptin resistance in PCOS rats has not been reported. This study aimed to investigate whether there was a state of central leptin resistance in PCOS rats, as well as explore the possible association of hypothalamic inflammation with central leptin resistance...
August 5, 2016: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/27219465/oral-contraceptives-versus-physical-exercise-on-cardiovascular-and-metabolic-risk-factors-in-women-with-polycystic-ovary-syndrome-a-randomized-controlled-trial
#14
F Orio, G Muscogiuri, F Giallauria, S Savastano, P Bottiglieri, D Tafuri, P Predotti, G Colarieti, A Colao, S Palomba
BACKGROUND: Although oral contraceptives (OCs) are one the most widespread therapy in young polycystic ovary syndrome (PCOS) women and physical exercise represents a crucial first step in the treatment of overweight and obese PCOS, no studies were performed to compare the effects on cardiovascular risk (CVR) of OCs and physical exercise in PCOS. OBJECTIVE: To compare the effects of OCs administration and physical exercise on the CVR, clinical, hormonal and metabolic parameters in PCOS women...
May 24, 2016: Clinical Endocrinology
https://www.readbyqxmd.com/read/27217417/calprotectin-is-a-potential-prognostic-marker-for-polycystic-ovary-syndrome
#15
Shouzhen Chen, Mei Jiang, Tao Ding, Junmei Wang, Ping Long
Background Calprotectin is an antimicrobial, calcium and zinc-binding heterocomplex protein and has been proposed as a marker to rule out inflammatory conditions. The aim of this study was to evaluate the role of calprotectin in the diagnosis of polycystic ovary syndrome and to investigate the association between calprotectin and insulin resistance. Methods A total of 41 females with polycystic ovary syndrome and 54 age-matched without polycystic ovary syndrome were eligible for the study. Serum concentration of calprotectin was determined using enzyme-linked immunosorbent assay...
March 2017: Annals of Clinical Biochemistry
https://www.readbyqxmd.com/read/27050252/the-effects-of-vitamin-d-k-calcium-co-supplementation-on-endocrine-inflammation-and-oxidative-stress-biomarkers-in-vitamin-d-deficient-women-with-polycystic-ovary-syndrome-a-randomized-double-blind-placebo-controlled-trial
#16
RANDOMIZED CONTROLLED TRIAL
M Razavi, M Jamilian, M Karamali, F Bahmani, E Aghadavod, Z Asemi
The current study was conducted to assess the effects of vitamin D-K-calcium co-supplementation on endocrine, inflammation, and oxidative stress biomarkers in vitamin D-deficient women with polycystic ovary syndrome (PCOS). This randomized double-blind, placebo-controlled trial was performed on 60 vitamin D-deficient women diagnosed with PCOS aged 18-40 years old. Participants were randomly allocated into 2 groups to intake either 200 IU vitamin D, 90 μg vitamin K plus, 500 mg calcium supplements (n=30), or placebo (n=30) twice a day for 8 weeks...
July 2016: Hormone and Metabolic Research, Hormon- und Stoffwechselforschung, Hormones et Métabolisme
https://www.readbyqxmd.com/read/27039809/the-icam-1-gly241arg-polymorphism-is-not-associated-with-polycystic-ovary-syndrome-results-from-a-case-control-study-in-kashmir-india
#17
Syed Douhath Yousuf, Mohammad Ashraf Ganie, Mohammad Afzal Zargar, Tabasum Parvez, Fouzia Rashid
BACKGROUND: Polycystic ovary syndrome (PCOS) is considered to be a multifactorial disorder resulting from the interaction of several predisposing and protective genetic variants. PCOS is associated with low-grade chronic inflammation. Elevated levels of inflammatory markers including intercellular adhesion molecule-1 (ICAM-1) are demonstrated in women with PCOS. Recent evidence indicates a significant linkage between a locus on chromosome 19p13 and multifactorial diseases that have an inflammatory component...
2016: Asian Pacific Journal of Cancer Prevention: APJCP
https://www.readbyqxmd.com/read/27034186/endocrine-and-metabolic-characteristics-in-polycystic-ovary-syndrome
#18
REVIEW
Dorte Glintborg
Hirsutism affects 5-25% women, and the condition is most often caused by polycystic ovary syndrome (PCOS). The initial evaluation of hirsute patients should include a thorough medical history, clinical evaluation, and standardized blood samples to diagnose the 5% hirsute patients with rare endocrine disorders. The majority of these examinations can be performed by the patient's general practitioner. PCOS is a diagnosis of exclusion and is a multiorgan disease affecting most endocrine organs including ovaries, adrenals, pituitary, fat cells, and endocrine pancreas...
April 2016: Danish Medical Journal
https://www.readbyqxmd.com/read/26980590/the-inflammatory-markers-in-polycystic-ovary-syndrome-association-with-obesity-and-ivf-outcomes
#19
COMPARATIVE STUDY
Y Çakıroğlu, F Vural, B Vural
OBJECTIVE: To investigate the inflammatory markers in polycystic ovary syndrome (PCOS) and associations of these markers with obesity and in vitro fertilization (IVF) outcomes. METHODS: A total of 292 women underwent IVF procedure either with PCOS (n = 146) or without PCOS (n = 146, age, and body mass index (BMI) matched controls) were included in the study. All patients were classified according to BMI levels (normal weight: NW, BMI <25 kg/m(2) and obese: OB, BMI ≥25 kg/m(2))...
August 2016: Journal of Endocrinological Investigation
https://www.readbyqxmd.com/read/26969461/a-possible-connection-between-tumor-necrosis-factor-alpha-and-adropin-levels-in-polycystic-ovary-syndrome
#20
COMPARATIVE STUDY
T Kume, M Calan, O Yilmaz, G U Kocabas, P Yesil, M Temur, M Bicer, O G Calan
CONTEXT: Adropin is a peptide hormone implicated in the regulation of insulin sensitivity and energy homeostasis. Polycystic ovary syndrome (PCOS) is a metabolic and reproductive disease associated with insulin resistance. It has been demonstrated that various inflammatory markers increased in PCOS including TNF-α. TNF-α regulates the secretion of certain peptides which play a crucial role in glucose and lipid homeostasis. There is also some evidence of a link between TNF-α and adropin...
July 2016: Journal of Endocrinological Investigation
keyword
keyword
29364
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"